results from a phase i trial of tinostamustine in patients with r/r classical hl
Published 7 months ago • 58 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
3:10
results of phase ii trial of olutasidenib in patients with r/r midh1 aml
-
1:39
phase i/ii trial of adct-602 in b-all
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
0:47
overview of the phase iii enhance trial schema
-
4:55
results of the phase ib/ii trial of obinutuzumab-atezolizumab-lenalidomide for r/r fl
-
1:25
preliminary results from a phase ib trial of as-1763, a novel non-covalent btki, in cll/mcl
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl